Page last updated: 2024-11-07

methylprednisolone acetate and Clinically Isolated CNS Demyelinating Syndrome

methylprednisolone acetate has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 2 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Research Excerpts

ExcerptRelevanceReference
"Clinical trials first began in 1960 with methylprednisolone acetate (Depo-Medrol) administered intrathecally, in an attempt to treat both disk disease and multiple sclerosis."4.77Dangers from methylprednisolone acetate therapy by intraspinal injection. ( Nelson, DA, 1988)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Almalki, DM1
Mudhafar, OY1
Alsaman, AS1
Mahmoud, AA1
Nelson, DA1

Reviews

1 review available for methylprednisolone acetate and Clinically Isolated CNS Demyelinating Syndrome

ArticleYear
Dangers from methylprednisolone acetate therapy by intraspinal injection.
    Archives of neurology, 1988, Volume: 45, Issue:7

    Topics: Demyelinating Diseases; Humans; Injections, Epidural; Injections, Spinal; Intervertebral Disc; Methy

1988

Other Studies

1 other study available for methylprednisolone acetate and Clinically Isolated CNS Demyelinating Syndrome

ArticleYear
Diagnostic uncertainty of tumefactive cystic demyelinating lesions.
    Neurosciences (Riyadh, Saudi Arabia), 2013, Volume: 18, Issue:2

    Topics: Brain; Child; Demyelinating Diseases; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; M

2013